- Home
- BRKR vs CELH Comparison
BRKR vs CELH Comparison
Compare BRKR & CELH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- CELH
- Stock Information
- Founded
- BRKR 1960
- CELH 2004
- Country
- BRKR United States
- CELH United States
- Employees
- BRKR N/A
- CELH N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- CELH Beverages (Production/Distribution)
- Sector
- BRKR Industrials
- CELH Consumer Staples
- Exchange
- BRKR Nasdaq
- CELH Nasdaq
- Market Cap
- BRKR 6.3B
- CELH 11.7B
- IPO Year
- BRKR 2000
- CELH N/A
- Fundamental
- Price
- BRKR $42.46
- CELH $46.37
- Analyst Decision
- BRKR Buy
- CELH Strong Buy
- Analyst Count
- BRKR 12
- CELH 17
- Target Price
- BRKR $54.50
- CELH $47.24
- AVG Volume (30 Days)
- BRKR 2.4M
- CELH 7.4M
- Earning Date
- BRKR 08-05-2025
- CELH 08-05-2025
- Dividend Yield
- BRKR 0.47%
- CELH N/A
- EPS Growth
- BRKR N/A
- CELH N/A
- EPS
- BRKR 0.52
- CELH 0.32
- Revenue
- BRKR $3,446,100,000.00
- CELH $1,329,198,000.00
- Revenue This Year
- BRKR $6.43
- CELH $60.22
- Revenue Next Year
- BRKR $4.21
- CELH $25.97
- P/E Ratio
- BRKR $80.90
- CELH $142.57
- Revenue Growth
- BRKR 14.84
- CELH N/A
- 52 Week Low
- BRKR $34.10
- CELH $21.10
- 52 Week High
- BRKR $72.94
- CELH $60.70
- Technical
- Relative Strength Index (RSI)
- BRKR 63.18
- CELH 70.71
- Support Level
- BRKR $40.71
- CELH $44.91
- Resistance Level
- BRKR $43.21
- CELH $47.69
- Average True Range (ATR)
- BRKR 1.71
- CELH 1.55
- MACD
- BRKR 0.38
- CELH 0.13
- Stochastic Oscillator
- BRKR 87.62
- CELH 81.87
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages, Celsius Essentials line (containing aminos), Celsius On-the-Go powder packets, and the recently acquired portfolio of Alani Nu energy drinks and snacks. Celsius dedicates its efforts to branding and innovation, while it largely utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.